Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Advanced search

Results 1 - 10 of 47
Results/page:
12 3 4 5 > 
ORTHOpedic randomized clinical trial with expanded bone marrow MSC and bioceramics versus autograft in long bone nonUNIONs
ID: 733288
Start date: 2017-01-01, End date: 2021-12-31
Current orthopaedic treatments permit spontaneous bone regeneration to unite and heal 90% bone injuries. Non-union associates pain and disability, often requiring biological enhancement. Regenerative medicine research suggests to the general public that alternative treatments...
Programme: H2020-EU.3.1.3.
Record Number: 207447
Last updated on: 2017-07-24
Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial
ID: 733379
Start date: 2017-01-01, End date: 2021-12-31
Ischemic stroke (IS), caused by occlusion of arteries that supply blood to the brain, remains a leading cause of mortality and morbidity in the world. Disruption of blood and oxygen supply to the brain leads to neuronal death in the ischemic core within minutes. The...
Programme: H2020-EU.3.1.3.
Record Number: 207449
Last updated on: 2017-05-23
Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer
ID: 733008
Start date: 2017-01-01, End date: 2022-12-31
IMMUNOSABR is geared towards opening up a new paradigm in treating metastatic cancer by obtaining clinical proof of concept for a novel bi-modal curative treatment strategy. High precision stereotactic ablative radiotherapy (SABR) is combined with immunotherapy to form a...
Programme: H2020-EU.3.1.3.
Record Number: 207443
Last updated on: 2017-07-17
Clinical validation of miniature wearable dialysis machine
ID: 733169
Start date: 2017-01-01, End date: 2019-06-30
The project aims to validate a miniature wearable dialysis machine in a clinical setting and to prepare the system for CE-marking. Wearable dialysis allows renal patients to dialyze conveniently and continuously at home or at work, independently from a fixed water supply, up...
Programme: H2020-EU.3.1.3.
Record Number: 207629
Last updated on: 2016-12-16
A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer
ID: 731623
Start date: 2017-12-01, End date: 2022-11-30
Cervical cancer (CxCa) is caused by high risk types of the human papillomavirus (a.o. HPV16). Prophylactic HPV vaccination is not the standard of care in all European countries, and where approved it is not sufficiently adopted. Once infected, these vaccines no longer prevent...
Programme: H2020-EU.3.1.3.
Record Number: 212591
Last updated on: 2018-01-18
Stem-cell based gene therapy for recombination deficient SCID (RECOMB)
ID: 755170
Start date: 2018-01-01, End date: 2022-12-31
Gene therapy for rare inherited immune disorders has become a clinical reality. Especially for SCID, two major types of SCID (ADA-SCID, X-SCID) have been successfully treated by autologous stem cell based gene therapy. However, for the most common group of SCID, the SCID...
Programme: H2020-EU.3.1.3.
Record Number: 212687
Last updated on: 2018-01-23
The artificial pancreas in children aged 1 to 7 years with type 1 diabetes
ID: 731560
Start date: 2017-01-01, End date: 2020-06-30
TYPE 1 DIABETES is one of the most COMMON CHRONIC diseases in children with a RAPID increase in number of cases particularly in young children. Type 1 diabetes is associated with LIFE-LONG dependency on insulin administration. POOR glucose control leads to diabetes...
Programme: H2020-EU.3.1.3.
Record Number: 207200
Last updated on: 2017-06-16
SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS
ID: 731875
Start date: 2017-01-01, End date: 2021-12-31
Liver cirrhosis is a very common chronic disease and one of the leading causes of death in European. Moreover, cirrhosis has a marked impact in patients quality of life and represents a major burden for health systems. Treatment of cirrhosis is currently based on symptomatic...
Programme: H2020-EU.3.1.3.
Record Number: 207204
Last updated on: 2017-06-02
Zika Preparedness Latin American Network
ID: 734584
Start date: 2016-10-01, End date: 2020-09-30
The ZikaPLAN initiative combines the strengths of 25 partners in Latin America, North America, Africa, Asia, and various centres in Europe to address the urgent research gaps (WP 1-8) in Zika, identifying short-and long term solutions (WP 9-10) and building a sustainable...
Programme: H2020-EU.3.1.3.
Record Number: 206848
Last updated on: 2017-08-05
Testing the value of a novel strategic approach and its cost efficacy to improve the poor outcomes in Cardiogenic Shock
ID: 754946
Start date: 2018-01-01, End date: 2022-12-31
Heart attacks are common and can leave survivors suffering cardiogenic shock (CGS), with its extremely high risk of early death (42% versus 4% for non-CGS) and high incidence of chronic heart failure, with its associated socio-economic disease burden (ill-health, recurrent...
Programme: H2020-EU.3.1.3.
Record Number: 212681
Last updated on: 2018-01-23
12 3 4 5 > 
List retrieved on: 2018-04-22
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top